Invesaro

Stocks Health care BON

NASDAQ · Health care

Bon Natural Life Ltd (BON)

Bon Natural Life Ltd reported revenue of $18.7M in fiscal 2025, down 21.7% from a year earlier. It posted a net loss of $2M. Operating cash flow minus capital spending left $134.3K of free cash flow in fiscal 2025. At September 30, 2025 it held $6.3M in cash against $1.9M of debt. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on January 23, 2026.

Watch BON in 60 seconds
Price
$1.20
-0.65% on the day · September 25, 2026
52-week range $0.98 to $2.34
Market cap
$9.8M
Revenue (FY2025)
$18.7M
-21.7% year on year
Net margin
-10.7%

What Bon Natural Life Ltd does

Bon Natural Life Ltd is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker BON.

Revenue and profit by year

Revenue
FY19: $16.4M $16.4M FY19FY21: $18.2M $18.2M FY21FY21: $25.5M $25.5M FY21FY22: $29.9M $29.9M FY22FY23: $29.5M $29.5M FY23FY24: $23.8M $23.8M FY24FY25: $18.7M $18.7M FY25
Net income
FY19: $2.6M $2.6M FY19FY21: $3M $3M FY21FY21: $4.6M $4.6M FY21FY22: $6.2M $6.2M FY22FY23: $4.6M $4.6M FY23FY24: $398.2K $398.2K FY24FY25: -$2M -$2M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$18.7M-$1.6M-$2M-$0.72$134.3K
2024$23.8M$1.9M$398.2K$4.14-$7.7M
2023$29.5M$5.9M$4.6M$124.92-$678.8K
2022$29.9M$6.6M$6.2M$185.63-$214.8K
2021$25.5M$5.4M$4.6M$170.58$4M
2021$18.2M$3.5M$3M$145.49$2.6M

Full financial statements: income, balance sheet and cash flow

Where BON ranks in Health care

Revenue$18.7M
#441 of 646 in Health care · Bottom 32%
Revenue growth-21.7%
#441 of 474 in Health care · Bottom 7%
Net margin-10.7%
#260 of 485 in Health care · Bottom 46%
Free cash flow margin0.7%
#208 of 440 in Health care · Top 47%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Bon Natural Life Ltd has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 23, 2026
  2. March 19, 2026
  3. February 17, 2026
  4. January 23, 2026
    Annual report (foreign issuer) 20-F · period to September 30, 2025Revenue fell 22% to $18.7M versus the prior year; diluted EPS -$0.72 versus $4.14.
  5. December 10, 2025
  6. November 25, 2025
  7. November 14, 2025
  8. November 10, 2025
  9. October 16, 2025
  10. September 29, 2025

Recent insider filings (Forms 3, 4 and 144): 8, the latest on May 15, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about BON

What does Bon Natural Life Ltd do?

Bon Natural Life Ltd is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker BON.

Is Bon Natural Life Ltd profitable?

No. In fiscal 2025 it reported a net loss of $2M on revenue of $18.7M.

How much revenue does Bon Natural Life Ltd make?

In fiscal 2025 Bon Natural Life Ltd reported revenue of $18.7M. That is 21.7% less than a year earlier.

When did Bon Natural Life Ltd last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on January 23, 2026. It covers the period to September 30, 2025. Its newest filing of any kind is the foreign issuer update from September 23, 2026.

Similar companies

Compare BON with

Compare BON with any company

Follow BON

Get an email when Bon Natural Life Ltd files with the SEC: results, executive changes, material agreements and annual reports.

Follow BON: get an email when it files

Where the numbers come from

Financial figures are the values Bon Natural Life Ltd tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.